Briacell TherapeuticsBCTXLPreferred / convertible
13F holders, Q2 2026 (June 30)10holders −5
0new positions
5sold out
1famous investor
$0.86avg. 13F price*
At the end of Q2 2026, 10 institutions reported holding Briacell Therapeutics Corp. (BCTXL) in their 13F filings, down 5 from Q1 2026. 0 opened new positions and 5 sold out. The largest holders were Citadel Advisors ($717K), Armistice Capital, LLC ($478K) and Cable Car Capital, LP ($286K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Briacell Therapeutics Corp.
- CUSIP
- 107930125
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 5 | $266K |
All 13F filers, Q1 2026 → Q2 2026: 44,555 shares bought and 662,586 shares sold, net −618,031 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Citadel Advisors | — | Reduce -14.6% | 895,864 | $717K |
| Armistice Capital, LLC | — | No change | 536,600 | $478K |
| Cable Car Capital, LP | — | No change | 321,898 | $286K |
| Empery Asset Management, LP | — | No change | 300,000 | $267K |
| MYDA Advisors LLC | — | Reduce -2.1% | 195,821 | $174K |
| Sabby Management, LLC | — | Reduce -50.0% | 190,383 | $169K |
| Heights Capital Management, Inc. | — | Reduce -37.8% | 186,582 | $149K |
| Warberg Asset Management LLC | — | Add +38.7% | 159,555 | $142K |
| Clear Street Group Inc. | — | No change | 104,196 | $93K |
| Iridian Asset Management LLC | — | No change | 65,000 | $58K |
"% of holder's portfolio" is BCTXL's weight in each manager's 13F, not the share of Briacell Therapeutics Corp. the manager owns.